• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

Italy sees hike in biotech R&D investments, at rate higher than EU average

cafead

Administrator
Staff member
  • cafead   Jun 02, 2021 at 11:33: AM
via A robust research and innovation ecosystem makes Italy an attractive life sciences hotspot, according to a post from an Italian trade delegation at Bio Digital 2021.

article source